10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
Posts Tagged ‘Incyte Corporation (NASDAQ:INCY)’
Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches
Incyte Corporation (NASDAQ:INCY) is one of the 8 cheap beginner stocks to buy right now.
8 Cheap Beginner Stocks to Buy Right Now
Talk of a slowing economy has once again gained popularity within economic circles.
Morgan Stanley Maintains Hold Rating on Incyte (INCY) Stock
On June 4, Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68.00.
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
12 AI Updates Worth Taking a Look At
In a Bloomberg interview, SandboxAQ CEO Jack Hidary started discussing the company's partnership with Saudi Aramco, which focuses on using AI to convert carbon emissions into ...
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
12 Best S&P 500 Stocks To Buy According to Analysts
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Biotech Stocks with Huge Potential
In this article, we will take a look at the 5 biotech stocks with huge potential.
12 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds.
13 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
5 Best Debt Free Stocks To Buy
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
5 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
13 Best Beaten Down Stocks To Buy Now
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
12 Cheap Biotech Stocks To Buy
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Analysts Are Downgrading These 10 Stocks
In this article, we will take a look at the 10 stocks that were recently downgraded by analysts.
5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
Why These 5 Stocks Are on the Move on Wednesday
In this article we take a look at five stocks on the move on Wednesday.
Hedge Funds Are Buying Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view.
Should You Buy Medivation Inc (MDVN)?
In the eyes of most stock holders, hedge funds are assumed to be worthless, outdated investment vehicles of yesteryear.
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
Is Seattle Genetics, Inc. (NASDAQ:SGEN) a healthy stock for your portfolio? The smart money is in a pessimistic mood.
Here is What Hedge Funds Think About Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) – Theravance Inc (THRX), Seattle Genetics, Inc. (SGEN)
Is Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) a healthy stock for your portfolio? The best stock pickers are buying.
Hedge Funds Aren’t Crazy About Theravance Inc (THRX) Anymore – Arena Pharmaceuticals, Inc. (ARNA), Questcor Pharmaceuticals Inc (QCOR)
If you'd ask most market participants, hedge funds are viewed as worthless, old financial tools of years past.
Do Hedge Funds and Insiders Love Incyte Corporation (NASDAQ:INCY)?
Incyte Corporation (NASDAQ:INCY) was in 15 hedge funds' portfolio at the end of the fourth quarter of 2012.
